ETOPOSIDE and PYREXIA

Overview

PYREXIA is the #7 most commonly reported adverse reaction for ETOPOSIDE, manufactured by Accord Healthcare Inc.. There are 3,240 FDA adverse event reports linking ETOPOSIDE to PYREXIA. This represents approximately 2.6% of all 126,466 adverse event reports for this drug.

Patients taking ETOPOSIDE who experience pyrexia should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

PYREXIA is a less commonly reported adverse event for ETOPOSIDE, but still significant enough to appear in the safety profile.

Other Side Effects of ETOPOSIDE

In addition to pyrexia, the following adverse reactions have been reported for ETOPOSIDE:

• OFF LABEL USE — 7,665 reports
• FEBRILE NEUTROPENIA — 7,293 reports
• NEUTROPENIA — 4,831 reports
• DRUG INEFFECTIVE — 4,493 reports
• DISEASE PROGRESSION — 4,288 reports
• THROMBOCYTOPENIA — 3,884 reports
• ANAEMIA — 3,175 reports
• PRODUCT USE IN UNAPPROVED INDICATION — 2,893 reports
• SEPSIS — 2,870 reports
• DEATH — 2,711 reports

Other Drugs Associated with PYREXIA

The following drugs have also been linked to pyrexia in FDA adverse event reports:

Does ETOPOSIDE cause PYREXIA?

PYREXIA has been reported as an adverse event in 3,240 FDA reports for ETOPOSIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is PYREXIA with ETOPOSIDE?

PYREXIA accounts for approximately 2.6% of all adverse event reports for ETOPOSIDE, making it a notable side effect.

What should I do if I experience PYREXIA while taking ETOPOSIDE?

If you experience pyrexia while taking ETOPOSIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Related Pages